Researchers are exploring the potential of 3D-printed implantable devices to treat type 1 diabetes. These small devices, designed for subcutaneous implantation, aim to enable patients to produce their own insulin. This innovative approach could offer a long-term solution for managing the disease, reducing reliance on external insulin injections or pumps. Further research and clinical trials are needed to assess the safety and efficacy of these devices before they become widely available.